Efficacy of Bismuth-based Quadruple Therapy as First-line Treatment for Clarithromycin-resistant Helicobacter pylori Infection

Similar Items

• Seven Days of Bismuth-Based Quadruple Therapy Is as Effective for the First-Line Treatment of Clarithromycin-Resistant Confirmed <i>Helicobacter pylori</i> Infection as 14 Days of Bismuth-Based Quadruple Therapy
  by: Sang-Gon Moon, et al.
  Published: (2022-07-01)
• Efficacy of Twice a Day Bismuth Quadruple Therapy for Second-Line Treatment of <i>Helicobacter pylori</i> Infection
  by: Jeemyoung Kim, et al.
  Published: (2022-01-01)
• Efficacy of a bismuth-based quadruple therapy regimen for Helicobacter pylori eradication in Saudi Arabia
  by: Fahad Alsohaibani, et al.
  Published: (2020-01-01)
• Effects of 14-days bismuth- and tetracycline-containing quadruple therapy with concomitant regimen for the first line Helicobacter pylori eradication
  by: Arash Kazemi, et al.
  Published: (2023-09-01)
• Efficacy comparison of 7- and 14-day P-CAB based bismuth-containing quadruple regimen with PPI based bismuth-containing quadruple regimen for Helicobacter pylori infection: rationale and design of an open-label, multicenter, randomized controlled trial
  by: Chang Kyo Oh, et al.
  Published: (2023-12-01)